133 related articles for article (PubMed ID: 3105246)
21. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
[TBL] [Abstract][Full Text] [Related]
22. Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
Verbist L
J Antimicrob Chemother; 1987 Sep; 20(3):363-72. PubMed ID: 3119552
[TBL] [Abstract][Full Text] [Related]
23. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Habiyaremye I; Verbist L; Vandepitte J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
[TBL] [Abstract][Full Text] [Related]
24. Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
Espinoza AM; Chin NX; Novelli A; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):663-70. PubMed ID: 3293524
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin.
Appelbaum PC; Spangler SK; Tamarree T
Chemotherapy; 1988; 34(1):40-5. PubMed ID: 3127127
[TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
Forsgren A
Scand J Infect Dis; 1985; 17(1):91-4. PubMed ID: 3158070
[TBL] [Abstract][Full Text] [Related]
27. [In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
Grimm H
Infection; 1986; 14 Suppl 3():S191-5. PubMed ID: 3093387
[TBL] [Abstract][Full Text] [Related]
28. Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers.
Machka K; Milatovic D
Eur J Clin Microbiol; 1987 Feb; 6(1):59-62. PubMed ID: 3106034
[TBL] [Abstract][Full Text] [Related]
29. The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.
King A; Shannon K; Phillips I
J Antimicrob Chemother; 1985 May; 15(5):551-8. PubMed ID: 3159712
[TBL] [Abstract][Full Text] [Related]
30. CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
Fuchs PC; Barry AL; Jones RN; Thornsberry C; Ayers LW; Gavan TL; Gerlach EH
Diagn Microbiol Infect Dis; 1987 Mar; 6(3):185-92. PubMed ID: 3471371
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.
Rotstein C; Amsterdam D; Beam TR; Mandell LA; Gorzynski EA
Diagn Microbiol Infect Dis; 1993 Jul; 17(1):85-91. PubMed ID: 8395375
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
Oliveira AD; D'Azevedo PA; Francisco W
Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
[TBL] [Abstract][Full Text] [Related]
33. In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.
Beskid G; Fallat V; Lipschitz ER; McGarry DH; Cleeland R; Chan K; Keith DD; Unowsky J
Antimicrob Agents Chemother; 1989 Jul; 33(7):1072-7. PubMed ID: 2782857
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.
Wise R; Andrews JM; Ashby JP; Matthews RS
Antimicrob Agents Chemother; 1988 May; 32(5):617-22. PubMed ID: 3134843
[TBL] [Abstract][Full Text] [Related]
35. The comparative in-vitro activity of ofloxacin.
Grüneberg RN; Felmingham D; O'Hare MD; Robbins MJ; Perry K; Wall RA; Ridgway GL
J Antimicrob Chemother; 1988 Sep; 22 Suppl C():9-19. PubMed ID: 3182468
[TBL] [Abstract][Full Text] [Related]
36. Activity of gatifloxacin against strains resistant to ofloxacin and ciprofloxacin and its ability to select for less susceptible bacterial variants.
Fung-Tomc J; Gradelski E; Huczko E; Minassian B; Bonner DP
Int J Antimicrob Agents; 2001 Jul; 18(1):77-80. PubMed ID: 11463531
[TBL] [Abstract][Full Text] [Related]
37. In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study.
Soussy CJ; Cluzel M; Ploy MC; Kitzis MD; Morel C; Bryskier A; Courvalin P
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():43-50. PubMed ID: 10404337
[TBL] [Abstract][Full Text] [Related]
38. Activity of JNJ-Q2, a novel fluoroquinolone, tested against Neisseria gonorrhoeae, including ciprofloxacin-resistant strains.
Biedenbach DJ; Turner LL; Jones RN; Farrell DJ
Diagn Microbiol Infect Dis; 2012 Oct; 74(2):204-6. PubMed ID: 22819604
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory and bactericidal activities of amifloxacin, a new quinolone carboxylic acid, compared with those of seven other antimicrobial agents.
Baltch AL; Sutphen NT; Smith RP; Conley PE
Clin Ther; 1984; 7(1):73-80. PubMed ID: 6440708
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD
Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
